GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » Book Value per Share

Livzon Pharmaceutical Group (SZSE:000513) Book Value per Share : ¥15.76 (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group Book Value per Share?

Livzon Pharmaceutical Group's book value per share for the quarter that ended in Mar. 2024 was ¥15.76.

During the past 12 months, Livzon Pharmaceutical Group's average Book Value Per Share Growth Rate was 3.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 5.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 6.40% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Livzon Pharmaceutical Group was 38.10% per year. The lowest was -4.10% per year. And the median was 8.10% per year.

Livzon Pharmaceutical Group's current price is ¥38.45. Its book value per share for the quarter that ended in Mar. 2024 was ¥15.76. Hence, today's PB Ratio of Livzon Pharmaceutical Group is 2.44.

During the past 13 years, the highest P/B Ratio of Livzon Pharmaceutical Group was 7.08. The lowest was 1.69. And the median was 3.21.


Livzon Pharmaceutical Group Book Value per Share Historical Data

The historical data trend for Livzon Pharmaceutical Group's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Book Value per Share Chart

Livzon Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.95 12.81 13.87 14.83 15.20

Livzon Pharmaceutical Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.27 14.34 14.58 15.20 15.76

Competitive Comparison of Livzon Pharmaceutical Group's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Livzon Pharmaceutical Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Livzon Pharmaceutical Group's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Livzon Pharmaceutical Group's PB Ratio distribution charts can be found below:

* The bar in red indicates where Livzon Pharmaceutical Group's PB Ratio falls into.



Livzon Pharmaceutical Group Book Value per Share Calculation

Livzon Pharmaceutical Group's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(14,042-0)/924
=15.20

Livzon Pharmaceutical Group's Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(14,606-0)/927
=15.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Livzon Pharmaceutical Group  (SZSE:000513) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Livzon Pharmaceutical Group Book Value per Share Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Livzon Pharmaceutical Group (SZSE:000513) Business Description

Traded in Other Exchanges
Address
38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines